← Eichor
Study identifier: NCT04330118 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Origin and Function of Eosinophilic Polynuclear During DRESS Syndrome

Condition: Drug Hypersensitivity · DRESS Syndrome  ·  Sponsor: University Hospital, Lille

PhaseN/A
Planned participants80
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

Drug Hypersensitivity Syndrome or DRESS for "Drug Reaction with Eosinophilia and Systemic Symptoms" is a serious drug allergy which can be life-threatening for patients with serious organ damage. The pathophysiology of DRESS is still not fully understood. In particular, no study has focused on the characterization of eosinophils, while paradoxically eosinophilia is one of the diagnostic criteria. Likewise, there is no data about the origin of eosinophils and few data are available concerning immune polarization of T-cells or the involvement of innate lymphoid cells type 2 in the recruitment of eosinophils. Our preliminary data on increase activation markers membrane expression of cutaneous eosinophils suggest that this approach could allow the identification of endotypes in which eosinophils are involved and contribute to organ damages. The correlation between tissue infiltration of eosinophils and their degree of activation would then justify the development of targeted therapeutic strategies in DRESS syndrome (anti-IL-5 therapy?). The aim of the project is: 1) Evaluate the activation status of circulating and cutaneous eosinophils in patients with DRESS compared with drug induced maculopapular exanthema without or with eosinophilia (but do not fulfill DRESS criteria) and healthy subjects; 2) Understand the pathophysiological mechanisms at the origin of this eosinophilia.

This description comes directly from the study's public registry record.

Talk to the study team

Delphine Staumont-Salle, MD,PhD  ·  0320444193  ·  delphine.salle@chru-lille.fr

Always discuss trial participation with your own doctor first.

Locations (11)

CH d'ArrasArras, FranceRecruiting
CH de BoulogneBoulogne-sur-Mer, FranceRecruiting
Assistance Publique - Hôpitaux de Paris - HENRI MONDORCréteil, FranceRecruiting
CH de DouaiDouai, FranceRecruiting
CH de DunkerqueDunkirk, FranceRecruiting
CH LENSLens, FranceRecruiting
Hop Claude Huriez Chr LilleLille, FranceRecruiting
Groupe Hospitalier de l'Institut Catholique de LilleLille, FranceRecruiting
CH de RoubaixRoubaix, FranceRecruiting
Hôpital FOCHSuresnes, FranceRecruiting
CH de ValenciennesValenciennes, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04330118